<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Getu MA</submitter><funding>Shenzhen Key Medical Discipline Construction Fund &amp;amp; Sanming Project of Medicine in Shenzhen</funding><funding>Shenzhen Key Medical Discipline Construction Fund &amp; Sanming Project of Medicine in Shenzhen</funding><funding>National Natural Science Foundation of China</funding><funding>Medicine-Engineering Interdisciplinary Research Foundation of Shenzhen University</funding><funding>Shenzhen Science and Technology Program</funding><pagination>11371</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11965372</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Previous observational studies have suggested a potential link between Type 1 Diabetes (T1D) and site-specific cancer risk. However, the nature of this association remains uncertain due to confounding factors, reverse causation, and biases inherent in observational research. To address this gap, we conducted a two-sample Mendelian randomization (MR) study to assess the causal relationship between T1D and 22 site-specific cancers. Using summary statistics from large-scale genome-wide association studies of European ancestry, comprising data on T1D (N = 520,580) and the 22 site-specific cancers, we selected single nucleotide polymorphisms strongly associated with T1D as instruments for our analysis. Causal relationships were primarily evaluated through inverse-variance weighting-based analys</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>A two-sample Mendelian randomization study of type 1 diabetes and the risk of 22 site-specific cancers.</pubmed_title><pmcid>PMC11965372</pmcid><funding_grant_id>GJHZ20220913143005010</funding_grant_id><funding_grant_id>2023YG019</funding_grant_id><funding_grant_id>SZSM202111002</funding_grant_id><funding_grant_id>82104596</funding_grant_id><pubmed_authors>Gong P</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Ying Y</pubmed_authors><pubmed_authors>Getu MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>A two-sample Mendelian randomization study of type 1 diabetes and the risk of 22 site-specific cancers.</name><description>Previous observational studies have suggested a potential link between Type 1 Diabetes (T1D) and site-specific cancer risk. However, the nature of this association remains uncertain due to confounding factors, reverse causation, and biases inherent in observational research. To address this gap, we conducted a two-sample Mendelian randomization (MR) study to assess the causal relationship between T1D and 22 site-specific cancers. Using summary statistics from large-scale genome-wide association studies of European ancestry, comprising data on T1D (N = 520,580) and the 22 site-specific cancers, we selected single nucleotide polymorphisms strongly associated with T1D as instruments for our analysis. Causal relationships were primarily evaluated through inverse-variance weighting-based analys</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-06-28T03:05:21.681Z</modification><creation>2025-06-28T03:05:21.681Z</creation></dates><accession>S-EPMC11965372</accession><cross_references><pubmed>40175445</pubmed><doi>10.1038/s41598-025-89288-3</doi></cross_references></HashMap>